Rodent models of heart failure: An updated review

Heart Failure Reviews

Volumn 18, Issue 2, 2013, Pages 219-249

  Gomes, A C ^a   Falcao Pires I ^a   Pires, A L ^a   Bras Silva C ^a   Leite Moreira, A F ^a  

^a University of Porto   (Portugal)

Author keywords

Animal models; Cardiovascular research; Diabetes mellitus; Heart failure; Rodents

Indexed keywords

DOXORUBICIN; HOMOCYSTEINE; ISOPRENALINE; MONOCROTALINE;

ARTICLE; CARDIOMYOPATHY; DAHL SALT SENSITIVE RAT; DIABETIC CARDIOMYOPATHY; DIASTOLIC HEART FAILURE; DISEASE MODEL; GENETIC ENGINEERING; HAMSTER; HEART FAILURE; HEART INFARCTION; HEART VENTRICLE OVERLOAD; MYOCARDITIS; NONHUMAN; PHARMACOLOGICAL PROCEDURES; SPONTANEOUSLY HYPERTENSIVE HEART FAILURE RAT; SPONTANEOUSLY HYPERTENSIVE RAT;

ANIMALS; DISEASE MODELS, ANIMAL; GENETIC THERAPY; HEART FAILURE; MYOCARDIUM; RODENTIA;

EID: 84879464622     PISSN: 13824147     EISSN: 15737322     Source Type: Journal    
DOI: 10.1007/s10741-012-9305-3     Document Type: Article

References (328)

1. Abbate A, Scarpa S, Santini D, Palleiro J, Vasaturo F, Miller J, Morales C, Vetrovec GW, Baldi A (2006) Myocardial expression of survivin, an apoptosis inhibitor, in aging and heart failure. An experimental study in the spontaneously hypertensive rat. Int J Cardiol 111:371-376. doi: 10.1016/j.ijcard.2005.07.061 (Pubitemid 44205288)
2. Akhter SA, Luttrell LM, Rockman HA, Iaccarino G, Lefkowitz RJ, Koch WJ (1998) Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy. Science 280:574-577 (Pubitemid 28227758)
3. Akhter SA, Milano CA, Shotwell KF, Cho MC, Rockman HA, Lefkowitz RJ, Koch WJ (1997) Transgenic mice with cardiac overexpression of alpha1B-adrenergic receptors. In vivo alpha1-adrenergic receptor-mediated regulation of beta-adrenergic signaling. J Biol Chem 272:21253-21259 (Pubitemid 27373990)
4. An D, Rodrigues B (2006) Role of changes in cardiac metabolism in development of diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol 291:H1489-1506. doi: 10.1152/ajpheart.00278.2006 (Pubitemid 44497651)
5. Anderson ME (2005) Calmodulin kinase signaling in heart: an intriguing candidate target for therapy of myocardial dysfunction and arrhythmias. Pharmacol Ther 106:39-55. doi: 10.1016/j.pharmthera.2004.11.002 (Pubitemid 40386719)
6. Antos CL, Frey N, Marx SO, Reiken S, Gaburjakova M, Richardson JA, Marks AR, Olson EN (2001) Dilated cardiomyopathy and sudden death resulting from constitutive activation of protein kinase a. Circ Res 89:997-1004 (Pubitemid 34640866)
7. Arber S, Hunter JJ, Ross J Jr, Hongo M, Sansig G, Borg J, Perriard JC, Chien KR, Caroni P (1997) MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure. Cell 88:393-403 (Pubitemid 27131381)
8. Arnolda L, McGrath B, Cocks M, Sumithran E, Johnston C (1985) Adriamycin cardiomyopathy in the rabbit: an animal model of low output cardiac failure with activation of vasoconstrictor mechanisms. Cardiovasc Res 19:378-382 (Pubitemid 15040580)
9. +-ATPase increases cardiac contractility in transgenic mouse hearts. Circ Res 83:1205-1214 (Pubitemid 29006035)
10. Bayat H, Swaney JS, Ander AN, Dalton N, Kennedy BP, Hammond HK, Roth DM (2002) Progressive heart failure after myocardial infarction in mice. Basic Res Cardiol 97:206-213 (Pubitemid 34464154)
11. Berg RG, Leenen FH, de Jong W (1979) Plasma renin activity and sodium, potassium and water excretion during reversal of hypertension in the one-clip two-kidney hypertensive rat. Clin Sci (Lond) 57:47-52 (Pubitemid 10155492)
12. Bialik GM, Abassi ZA, Hammel I, Winaver J, Lewinson D (2001) Evaluation of atrial natriuretic peptide and brain natriuretic peptide in atrial granules of rats with experimental congestive heart failure. J Histochem Cytochem 49:1293-1300 (Pubitemid 32885393)
13. Bing OH, Brooks WW, Robinson KG, Slawsky MT, Hayes JA, Litwin SE, Sen S, Conrad CH (1995) The spontaneously hypertensive rat as a model of the transition from compensated left ventricular hypertrophy to failure. J Mol Cell Cardiol 27:383-396
14. Bittner HB, Chen EP, Milano CA, Lefkowitz RJ, Van Trigt P (1997) Functional analysis of myocardial performance in murine hearts overexpressing the human beta 2-adrenergic receptor. J Mol Cell Cardiol 29:961-967. doi: 10.1006/jmcc.1996.0339 (Pubitemid 27196523)
15. Boluyt MO, O'Neill L, Meredith AL, Bing OH, Brooks WW, Conrad CH, Crow MT, Lakatta EG (1994) Alterations in cardiac gene expression during the transition from stable hypertrophy to heart failure. Marked upregulation of genes encoding extracellular matrix components. Circ Res 75:23-32 (Pubitemid 24187732)
16. Boluyt MO, Robinson KG, Meredith AL, Sen S, Lakatta EG, Crow MT, Brooks WW, Conrad CH, Bing OH (2005) Heart failure after long-term supravalvular aortic constriction in rats. Am J Hypertens 18:202-212. doi: 10.1016/j.amjhyper.2004. 08.034 (Pubitemid 40332550)
17. Bond RA, Leff P, Johnson TD, Milano CA, Rockman HA, McMinn TR, Apparsundaram S, Hyek MF, Kenakin TP, Allen LF, et al. (1995) Physiological effects of inverse agonists in transgenic mice with myocardial overexpression of the beta 2-adrenoceptor. Nature 374:272-276. doi: 10.1038/374272a0
18. Boudina S, Abel ED (2007) Diabetic cardiomyopathy revisited. Circulation 115:3213-3223. doi: 10.1161/CIRCULATIONAHA.106.679597 (Pubitemid 47012236)
19. Boudina S, Sena S, Theobald H, Sheng X, Wright JJ, Hu XX, Aziz S, Johnson JI, Bugger H, Zaha VG, Abel ED (2007) Mitochondrial energetics in the heart in obesity-related diabetes: direct evidence for increased uncoupled respiration and activation of uncoupling proteins. Diabetes 56:2457-2466. doi: 10.2337/db07-0481 (Pubitemid 47523253)
20. Brancaccio M, Fratta L, Notte A, Hirsch E, Poulet R, Guazzone S, De Acetis M, Vecchione C, Marino G, Altruda F, Silengo L, Tarone G, Lembo G (2003) Melusin, a muscle-specific integrin beta1-interacting protein, is required to prevent cardiac failure in response to chronic pressure overload. Nat Med 9:68-75. doi: 10.1038/nm805nm805 (Pubitemid 36098262)
21. Bras-Silva C, Fontes-Sousa AP, Moura C, Areias JC, Leite-Moreira AF (2006) Impaired response to ET(B) receptor stimulation in heart failure: functional evidence of endocardial endothelial dysfunction? Exp Biol Med (Maywood) 231:893-898
22. Bras-Silva C, Leite-Moreira AF (2008) Myocardial effects of endothelin-1. Rev Port Cardiol 27:925-951
23. Braun A, Trigatti BL, Post MJ, Sato K, Simons M, Edelberg JM, Rosenberg RD, Schrenzel M, Krieger M (2002) Loss of SR-BI expression leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-deficient mice. Circ Res 90:270-276 (Pubitemid 34633927)
24. Braunschweig F, Cowie MR, Auricchio A (2011) What are the costs of heart failure? Europace 13(Suppl 2):ii13-17. doi: 10.1093/europace/eur081
25. Brede M, Wiesmann F, Jahns R, Hadamek K, Arnolt C, Neubauer S, Lohse MJ, Hein L (2002) Feedback inhibition of catecholamine release by two different alpha2-adrenoceptor subtypes prevents progression of heart failure. Circulation 106:2491-2496 (Pubitemid 35278807)
26. Brenner DA, Apstein CS, Saupe KW (2001) Exercise training attenuates age-associated diastolic dysfunction in rats. Circulation 104:221-226 (Pubitemid 32655842)
27. Bristow MR, Thompson PD, Martin RP, Mason JW, Billingham ME, Harrison DC (1978) Early anthracycline cardiotoxicity. Am J Med 65:823-832 (Pubitemid 9078065)
28. Brower GL, Levick SP, Janicki JS (2007) Inhibition of matrix metalloproteinase activity by ACE inhibitors prevents left ventricular remodeling in a rat model of heart failure. Am J Physiol Heart Circ Physiol 292:H3057-3064. doi: 10.1152/ajpheart.00447.2006 (Pubitemid 47084560)
29. Brown L, Ooi SY, Lau K, Sernia C (2000) Cardiac and vascular responses in deoxycorticosterone acetate-salt hypertensive rats. Clin Exp Pharmacol Physiol 27:263-269 (Pubitemid 30194163)
30. Buermans HP, Redout EM, Schiel AE, Musters RJ, Zuidwijk M, Eijk PP, van Hardeveld C, Kasanmoentalib S, Visser FC, Ylstra B, Simonides WS (2005) Microarray analysis reveals pivotal divergent mRNA expression profiles early in the development of either compensated ventricular hypertrophy or heart failure. Physiol Genomics 21:314-323. doi: 10.1152/physiolgenomics.00185.2004 (Pubitemid 40898491)
31. Bugger H, Abel ED (2008) Molecular mechanisms for myocardial mitochondrial dysfunction in the metabolic syndrome. Clin Sci (Lond) 114:195-210. doi: 10.1042/CS20070166 (Pubitemid 351293995)
32. Burke SL, Evans RG, Head GA (2011) Effects of chronic sympatho-inhibition on renal excretory function in renovascular hypertension. J Hypertens 29:945-952. doi: 10.1097/HJH.0b013e3283449529
33. Calderone A, de Champlain J, Rouleau JL (1991) Adriamycin-induced changes to the myocardial beta-adrenergic system in the rabbit. J Mol Cell Cardiol 23:333-342
34. Cantor EJ, Babick AP, Vasanji Z, Dhalla NS, Netticadan T (2005) A comparative serial echocardiographic analysis of cardiac structure and function in rats subjected to pressure or volume overload. J Mol Cell Cardiol 38:777-786. doi: 10.1016/j.yjmcc.2005.02.012 (Pubitemid 40591742)
35. Carvalho KA, Guarita-Souza LC, Hansen P, Rebelatto CL, Senegaglia AC, Miyague N, Olandoski M, Francisco JC, Furuta M, Gremski W (2006) Cell transplantation after the coculture of skeletal myoblasts and mesenchymal stem cells in the regeneration of the myocardium scar: an experimental study in rats. Transplant Proc 38:1596-1602. doi: 10.1016/j.transproceed.2006.03.023
36. Cavallero S, Gonzalez GE, Puyo AM, Roson MI, Perez S, Morales C, Hertig CM, Gelpi RJ, Fernandez BE (2007) Atrial natriuretic peptide behaviour and myocyte hypertrophic profile in combined pressure and volume-induced cardiac hypertrophy. J Hypertens 25:1940-1950. doi: 10.1097/HJH. 0b013e3282435b1e00004872-200709000-00026 (Pubitemid 47356636)
37. Chekanov VS (1999) A stable model of chronic bilateral ventricular insufficiency (dilated cardiomyopathy) induced by arteriovenous anastomosis and doxorubicin administration in sheep. J Thorac Cardiovasc Surg 117:198-199 (Pubitemid 29022272)
38. Chen H, Charlat O, Tartaglia LA, Woolf EA, Weng X, Ellis SJ, Lakey ND, Culpepper J, Moore KJ, Breitbart RE, Duyk GM, Tepper RI, Morgenstern JP (1996) Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 84:491-495 (Pubitemid 26060722)
39. Chen J, Chien KR (1999) Complexity in simplicity: monogenic disorders and complex cardiomyopathies. J Clin Invest 103:1483-1485. doi: 10.1172/JCI7297
40. Chen Y, Daosukho C, Opii WO, Turner DM, Pierce WM, Klein JB, Vore M, Butterfield DA, St Clair DK (2006) Redox proteomic identification of oxidized cardiac proteins in adriamycin-treated mice. Free Radic Biol Med 41:1470-1477. doi: 10.1016/j.freeradbiomed.2006.08.006 (Pubitemid 44466730)
41. Chua SC Jr, Chung WK, Wu-Peng XS, Zhang Y, Liu SM, Tartaglia L, Leibel RL (1996) Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science 271:994-996 (Pubitemid 26066874)
42. Cohn JN (2002) Sympathetic nervous system in heart failure. Circulation 106:2417-2418 (Pubitemid 35278794)
43. Colbert MC, Hall DG, Kimball TR, Witt SA, Lorenz JN, Kirby ML, Hewett TE, Klevitsky R, Robbins J (1997) Cardiac compartment-specific overexpression of a modified retinoic acid receptor produces dilated cardiomyopathy and congestive heart failure in transgenic mice. J Clin Invest 100:1958-1968. doi: 10.1172/JCI119727 (Pubitemid 27459349)
44. Coral-Vazquez R, Cohn RD, Moore SA, Hill JA, Weiss RM, Davisson RL, Straub V, Barresi R, Bansal D, Hrstka RF, Williamson R, Campbell KP (1999) Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: a novel mechanism for cardiomyopathy and muscular dystrophy. Cell 98:465-474 (Pubitemid 29402484)
45. Creemers EE, Davis JN, Parkhurst AM, Leenders P, Dowdy KB, Hapke E, Hauet AM, Escobar PG, Cleutjens JP, Smits JF, Daemen MJ, Zile MR, Spinale FG (2003) Deficiency of TIMP-1 exacerbates LV remodeling after myocardial infarction in mice. Am J Physiol Heart Circ Physiol 284:H364-371. doi: 10.1152/ajpheart.00511. 2002
46. Cunha-Neto E, Dzau VJ, Allen PD, Stamatiou D, Benvenutti L, Higuchi ML, Koyama NS, Silva JS, Kalil J, Liew CC (2005) Cardiac gene expression profiling provides evidence for cytokinopathy as a molecular mechanism in Chagas' disease cardiomyopathy. Am J Pathol 167:305-313. doi: 10.1016/S0002-9440(10)62976-8 (Pubitemid 43026088)
47. D'Angelo DD, Sakata Y, Lorenz JN, Boivin GP, Walsh RA, Liggett SB, Dorn GW 2nd (1997) Transgenic Galphaq overexpression induces cardiac contractile failure in mice. Proc Natl Acad Sci USA 94:8121-8126 (Pubitemid 27343787)
48. Dahl LK, Heine M, Tassinari L (1962) Role of genetic factors in susceptibility to experimental hypertension due to chronic excess salt ingestion. Nature 194:480-482
49. Dash R, Kadambi V, Schmidt AG, Tepe NM, Biniakiewicz D, Gerst MJ, Canning AM, Abraham WT, Hoit BD, Liggett SB, Lorenz JN, Dorn GW 2nd, Kranias EG (2001) Interactions between phospholamban and beta-adrenergic drive may lead to cardiomyopathy and early mortality. Circulation 103:889-896 (Pubitemid 32163890)
50. De Angelis A, Piegari E, Cappetta D, Marino L, Filippelli A, Berrino L, Ferreira-Martins J, Zheng H, Hosoda T, Rota M, Urbanek K, Kajstura J, Leri A, Rossi F, Anversa P (2010) Anthracycline cardiomyopathy is mediated by depletion of the cardiac stem cell pool and is rescued by restoration of progenitor cell function. Circulation 121:276-292. doi: 10.1161/CIRCULATIONAHA.109.895771
51. Delgado RM 3rd, Nawar MA, Zewail AM, Kar B, Vaughn WK, Wu KK, Aleksic N, Sivasubramanian N, McKay K, Mann DL, Willerson JT (2004) Cyclooxygenase-2 inhibitor treatment improves left ventricular function and mortality in a murine model of doxorubicin-induced heart failure. Circulation 109:1428-1433. doi: 10.1161/01.CIR.0000121354.34067.48 (Pubitemid 38387831)
52. Devi S, Kennedy RH, Joseph L, Shekhawat NS, Melchert RB, Joseph J (2006) Effect of long-term hyperhomocysteinemia on myocardial structure and function in hypertensive rats. Cardiovasc Pathol 15:75-82. doi: 10.1016/j.carpath.2005.11. 001
53. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Stromberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K (2008) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 10:933-989. doi: 10.1016/j.ejheart.2008.08.005
54. Dodd DA, Atkinson JB, Olson RD, Buck S, Cusack BJ, Fleischer S, Boucek RJ Jr (1993) Doxorubicin cardiomyopathy is associated with a decrease in calcium release channel of the sarcoplasmic reticulum in a chronic rabbit model. J Clin Invest 91:1697-1705. doi: 10.1172/JCI116379 (Pubitemid 23127375)
55. Doi R, Masuyama T, Yamamoto K, Doi Y, Mano T, Sakata Y, Ono K, Kuzuya T, Hirota S, Koyama T, Miwa T, Hori M (2000) Development of different phenotypes of hypertensive heart failure: systolic versus diastolic failure in Dahl salt-sensitive rats. J Hypertens 18:111-120 (Pubitemid 30093716)
56. Drolet MC, Lachance D, Plante E, Roussel E, Couet J, Arsenault M (2006) Gender-related differences in left ventricular remodeling in chronic severe aortic valve regurgitation in rats. J Heart Valve Dis 15:345-351
57. Du XJ, Autelitano DJ, Dilley RJ, Wang B, Dart AM, Woodcock EA (2000) beta(2)-adrenergic receptor overexpression exacerbates development of heart failure after aortic stenosis. Circulation 101:71-77 (Pubitemid 30039079)
58. Du XJ, Gao XM, Wang B, Jennings GL, Woodcock EA, Dart AM (2000) Age-dependent cardiomyopathy and heart failure phenotype in mice overexpressing beta(2)-adrenergic receptors in the heart. Cardiovasc Res 48:448-454
59. Du XJ, Vincan E, Woodcock DM, Milano CA, Dart AM, Woodcock EA (1996) Response to cardiac sympathetic activation in transgenic mice overexpressing beta 2-adrenergic receptor. Am J Physiol 271:H630-H636
60. Dubi S, Arbel Y (2010) Large animal models for diastolic dysfunction and diastolic heart failure-a review of the literature. Cardiovasc Pathol 19:147-152. doi: 10.1016/j.carpath.2008.12.008
61. Ducharme A, Frantz S, Aikawa M, Rabkin E, Lindsey M, Rohde LE, Schoen FJ, Kelly RA, Werb Z, Libby P, Lee RT (2000) Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J Clin Invest 106:55-62. doi: 10.1172/JCI8768 (Pubitemid 30437240)
62. El-Demerdash E, Awad AS, Taha RM, El-Hady AM, Sayed-Ahmed MM (2005) Probucol attenuates oxidative stress and energy decline in isoproterenol-induced heart failure in rat. Pharmacol Res 51:311-318. doi: 10.1016/j.phrs.2004.10.002 (Pubitemid 40430804)
63. Engelhardt S, Boknik P, Keller U, Neumann J, Lohse MJ, Hein L (2001) Early impairment of calcium handling and altered expression of junctin in hearts of mice overexpressing the beta1-adrenergic receptor. FASEB J 15:2718-2720. doi: 10.1096/fj.01-0107fje
64. Engelhardt S, Hein L, Dyachenkow V, Kranias EG, Isenberg G, Lohse MJ (2004) Altered calcium handling is critically involved in the cardiotoxic effects of chronic beta-adrenergic stimulation. Circulation 109:1154-1160. doi: 10.1161/01.CIR.0000117254.68497.39 (Pubitemid 38332620)
65. Engelhardt S, Hein L, Wiesmann F, Lohse MJ (1999) Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice. Proc Natl Acad Sci USA 96:7059-7064 (Pubitemid 29275009)
66. Escobales N, Crespo MJ (2008) Early pathophysiological alterations in experimental cardiomyopathy: the Syrian cardiomyopathic hamster. P R Health Sci J 27:307-314
67. Esposito G, Rapacciuolo A, Naga Prasad SV, Takaoka H, Thomas SA, Koch WJ, Rockman HA (2002) Genetic alterations that inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress. Circulation 105:85-92 (Pubitemid 34049147)
68. Fairweather D, Kaya Z, Shellam GR, Lawson CM, Rose NR (2001) From infection to autoimmunity. J Autoimmun 16:175-186. doi: 10.1006/jaut.2000.0492 (Pubitemid 32566105)
69. Falcao-Pires I, Palladini G, Goncalves N, van der Velden J, Moreira-Goncalves D, Miranda-Silva D, Salinaro F, Paulus WJ, Niessen HW, Perlini S, Leite-Moreira AF (2011) Distinct mechanisms for diastolic dysfunction in diabetes mellitus and chronic pressure-overload. Basic Res Cardiol 106:801-814. doi: 10.1007/s00395-011-0184-x
70. Feldman AM, Weinberg EO, Ray PE, Lorell BH (1993) Selective changes in cardiac gene expression during compensated hypertrophy and the transition to cardiac decompensation in rats with chronic aortic banding. Circ Res 73:184-192 (Pubitemid 23173069)
71. Finck BN, Lehman JJ, Leone TC, Welch MJ, Bennett MJ, Kovacs A, Han X, Gross RW, Kozak R, Lopaschuk GD, Kelly DP (2002) The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. J Clin Invest 109:121-130. doi: 10.1172/JCI14080 (Pubitemid 34052548)
72. Francis GS, Tang WH (2003) Pathophysiology of congestive heart failure. Rev Cardiovasc Med 4(Suppl 2):S14-S20
73. Freeman RH, Davis JO, Watkins BE, Stephens GA, DeForrest JM (1979) Effects of continuous converting enzyme blockade on renovascular hypertension in the rat. Am J Physiol 236:F21-F24
74. Fu M, Matoba M, Liang QM, Sjogren KG, Hjalmarson A (1994) Properties of G-protein modulated receptor-adenylyl cyclase system in myocardium of spontaneously hypertensive rats treated with adriamycin. Int J Cardiol 44:9-18 (Pubitemid 24110043)
75. Fujihira S, Yamamoto T, Matsumoto M, Yoshizawa K, Oishi Y, Fujii T, Noguchi H, Mori H (1993) The high incidence of atrial thrombosis in mice given doxorubicin. Toxicol Pathol 21:362-368 (Pubitemid 23326511)
76. Gao XM, Dart AM, Dewar E, Jennings G, Du XJ (2000) Serial echocardiographic assessment of left ventricular dimensions and function after myocardial infarction in mice. Cardiovasc Res 45:330-338 (Pubitemid 30069498)
77. Garcia R, Diebold S (1990) Simple, rapid, and effective method of producing aortocaval shunts in the rat. Cardiovasc Res 24:430-432 (Pubitemid 20179596)
78. Gaudin PB, Hruban RH, Beschorner WE, Kasper EK, Olson JL, Baughman KL, Hutchins GM (1993) Myocarditis associated with doxorubicin cardiotoxicity. Am J Clin Pathol 100:158-163 (Pubitemid 23251886)
79. Gehrmann J, Frantz S, Maguire CT, Vargas M, Ducharme A, Wakimoto H, Lee RT, Berul CI (2001) Electrophysiological characterization of murine myocardial ischemia and infarction. Basic Res Cardiol 96:237-250 (Pubitemid 32433058)
80. Georgakopoulos D, Mitzner WA, Chen CH, Byrne BJ, Millar HD, Hare JM, Kass DA (1998) In vivo murine left ventricular pressure-volume relations by miniaturized conductance micromanometry. Am J Physiol 274:H1416-H1422
81. Goldblatt H, Lynch J, Hanzal RF, Summerville WW (1934) Studies on Experimental Hypertension: I. The production of persistent elevation of systolic blood pressure by means of renal ischemia. J Exp Med 59:347-379
82. Gomez AM, Valdivia HH, Cheng H, Lederer MR, Santana LF, Cannell MB, McCune SA, Altschuld RA, Lederer WJ (1997) Defective excitation-contraction coupling in experimental cardiac hypertrophy and heart failure. Science 276:800-806 (Pubitemid 27199861)
83. Goser S, Andrassy M, Buss SJ, Leuschner F, Volz CH, Ottl R, Zittrich S, Blaudeck N, Hardt SE, Pfitzer G, Rose NR, Katus HA, Kaya Z (2006) Cardiac troponin I but not cardiac troponin T induces severe autoimmune inflammation in the myocardium. Circulation 114:1693-1702. doi: 10.1161/CIRCULATIONAHA.106. 635664 (Pubitemid 44607117)
84. Goto Y, Suzuki K, Ono T, Sasaki M, Toyota T (1988) Development of diabetes in the non-obese NIDDM rat (GK rat). Adv Exp Med Biol 246:29-31
85. Gould KE, Taffet GE, Michael LH, Christie RM, Konkol DL, Pocius JS, Zachariah JP, Chaupin DF, Daniel SL, Sandusky GE Jr, Hartley CJ, Entman ML (2002) Heart failure and greater infarct expansion in middle-aged mice: a relevant model for postinfarction failure. Am J Physiol Heart Circ Physiol 282:H615-H621. doi: 10.1152/ajpheart.00206.2001
86. Grady RM, Teng H, Nichol MC, Cunningham JC, Wilkinson RS, Sanes JR (1997) Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy. Cell 90:729-738 (Pubitemid 27357964)
87. Greer JJ, Ware DP, Lefer DJ (2006) Myocardial infarction and heart failure in the db/db diabetic mouse. Am J Physiol Heart Circ Physiol 290:H146-153. doi: 10.1152/ajpheart.00583.2005
88. Grimm D, Elsner D, Schunkert H, Pfeifer M, Griese D, Bruckschlegel G, Muders F, Riegger GA, Kromer EP (1998) Development of heart failure following isoproterenol administration in the rat: role of the renin-angiotensin system. Cardiovasc Res 37:91-100 (Pubitemid 28122620)
89. Grobe JL, Mecca AP, Mao H, Katovich MJ (2006) Chronic angiotensin-(1-7) prevents cardiac fibrosis in DOCA-salt model of hypertension. Am J Physiol Heart Circ Physiol 290:H2417-2423. doi: 10.1152/ajpheart.01170.2005 (Pubitemid 43846070)
90. Gruver CL, DeMayo F, Goldstein MA, Means AR (1993) Targeted developmental overexpression of calmodulin induces proliferative and hypertrophic growth of cardiomyocytes in transgenic mice. Endocrinology 133:376-388 (Pubitemid 23206418)
91. Haghighi K, Schmidt AG, Hoit BD, Brittsan AG, Yatani A, Lester JW, Zhai J, Kimura Y, Dorn GW 2nd, MacLennan DH, Kranias EG (2001) Superinhibition of sarcoplasmic reticulum function by phospholamban induces cardiac contractile failure. J Biol Chem 276:24145-24152. doi: 10.1074/jbc.M102403200
92. Halapas A, Papalois A, Stauropoulou A, Philippou A, Pissimissis N, Chatzigeorgiou A, Kamper E, Koutsilieris M (2008) In vivo models for heart failure research. In Vivo 22:767-780
93. Halapas A, Pissimissis N, Lembessis P, Rizos I, Rigopoulos AG, Kremastinos DT, Koutsilieris M (2008) Molecular diagnosis of the viral component in cardiomyopathies: pathophysiological, clinical and therapeutic implications. Expert Opin Ther Targets 12:821-836. doi: 10.1517/14728222.12.7.821 (Pubitemid 352005746)
94. Hara M, Ono K, Hwang MW, Iwasaki A, Okada M, Nakatani K, Sasayama S, Matsumori A (2002) Evidence for a role of mast cells in the evolution to congestive heart failure. J Exp Med 195:375-381 (Pubitemid 34461496)
95. Harding VB, Jones LR, Lefkowitz RJ, Koch WJ, Rockman HA (2001) Cardiac beta ARK1 inhibition prolongs survival and augments beta blocker therapy in a mouse model of severe heart failure. Proc Natl Acad Sci USA 98:5809-5814. doi: 10.1073/pnas.091102398 (Pubitemid 32435724)
96. Hayashidani S, Tsutsui H, Ikeuchi M, Shiomi T, Matsusaka H, Kubota T, Imanaka-Yoshida K, Itoh T, Takeshita A (2003) Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction. Am J Physiol Heart Circ Physiol 285:H1229-1235. doi: 10.1152/ajpheart.00207.2003
97. +ATPase gene in the heart of transgenic mice accelerates calcium transients and cardiac relaxation. J Clin Invest 100:380-389. doi: 10.1172/JCI119544 (Pubitemid 27349085)
98. Herman EH, Ferrans VJ (1998) Preclinical animal models of cardiac protection from anthracycline-induced cardiotoxicity. Semin Oncol 25:15-21 (Pubitemid 28460379)
99. Hessel MH, Steendijk P, den Adel B, Schutte CI, van der Laarse A (2006) Characterization of right ventricular function after monocrotaline-induced pulmonary hypertension in the intact rat. Am J Physiol Heart Circ Physiol 291:H2424-2430. doi: 10.1152/ajpheart.00369.2006
100. Heyen JR, Blasi ER, Nikula K, Rocha R, Daust HA, Frierdich G, Van Vleet JF, De Ciechi P, McMahon EG, Rudolph AE (2002) Structural, functional, and molecular characterization of the SHHF model of heart failure. Am J Physiol Heart Circ Physiol 283:H1775-H1784. doi: 10.1152/ajpheart.00305.2002
101. Heymans S, Hirsch E, Anker SD, Aukrust P, Balligand JL, Cohen-Tervaert JW, Drexler H, Filippatos G, Felix SB, Gullestad L, Hilfiker-Kleiner D, Janssens S, Latini R, Neubauer G, Paulus WJ, Pieske B, Ponikowski P, Schroen B, Schultheiss HP, Tschope C, Van Bilsen M, Zannad F, McMurray J, Shah AM (2009) Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 11:119-129. doi: 10.1093/eurjhf/hfn043
102. Heymans S, Pauschinger M, De Palma A, Kallwellis-Opara A, Rutschow S, Swinnen M, Vanhoutte D, Gao F, Torpai R, Baker AH, Padalko E, Neyts J, Schultheiss HP, Van de Werf F, Carmeliet P, Pinto YM (2006) Inhibition of urokinase-type plasminogen activator or matrix metalloproteinases prevents cardiac injury and dysfunction during viral myocarditis. Circulation 114:565-573. doi: 10.1161/CIRCULATIONAHA.105.591032 (Pubitemid 44199646)
103. Hibbs RG, Ferrans VJ, Walsh JJ, Burch GE (1965) Electron microscopic observations on lysosomes and related cytoplasmic components of normal and pathological cardiac muscle. Anat Rec 153:173-185
104. Hirono S, Islam MO, Nakazawa M, Yoshida Y, Kodama M, Shibata A, Izumi T, Imai S (1997) Expression of inducible nitric oxide synthase in rat experimental autoimmune myocarditis with special reference to changes in cardiac hemodynamics. Circ Res 80:11-20 (Pubitemid 27030363)
105. Hirota H, Chen J, Betz UA, Rajewsky K, Gu Y, Ross J Jr, Muller W, Chien KR (1999) Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress. Cell 97:189-198 (Pubitemid 29194270)
106. Hirota H, Yoshida K, Kishimoto T, Taga T (1995) Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice. Proc Natl Acad Sci USA 92:4862-4866
107. Holycross BJ, Summers BM, Dunn RB, McCune SA (1997) Plasma renin activity in heart failure-prone SHHF/Mcc-facp rats. Am J Physiol 273:H228-H233
108. Homburger F (1979) Myopathy of hamster dystrophy: history and morphologic aspects. Ann N Y Acad Sci 317:1-17
109. Homburger F, Baker JR, Nixon CW, Wilgram G (1962) New hereditary disease of Syrian hamsters. Primary, generalized polymyopathy and cardiac necrosis. Arch Intern Med 110:660-662
110. Homburger F, Nixon CW, Eppenberger M, Baker JR (1966) Hereditary myopathy in the Syrian hamster: studies on pathogenesis. Ann N Y Acad Sci 138:14-27
111. Hu P, Zhang D, Swenson L, Chakrabarti G, Abel ED, Litwin SE (2003) Minimally invasive aortic banding in mice: effects of altered cardiomyocyte insulin signaling during pressure overload. Am J Physiol Heart Circ Physiol 285:H1261-1269. doi: 10.1152/ajpheart.00108.2003
112. Huang WY, Aramburu J, Douglas PS, Izumo S (2000) Transgenic expression of green fluorescence protein can cause dilated cardiomyopathy. Nat Med 6:482-483. doi: 10.1038/74914 (Pubitemid 30305874)
113. Hunter EG, Hughes V, White J (1984) Cardiomyopathic hamsters, CHF 146 and CHF 147: a preliminary study. Can J Physiol Pharmacol 62:1423-1428 (Pubitemid 15222898)
114. Hunter JJ, Tanaka N, Rockman HA, Ross J Jr, Chien KR (1995) Ventricular expression of a MLC-2v-ras fusion gene induces cardiac hypertrophy and selective diastolic dysfunction in transgenic mice. J Biol Chem 270:23173-23178
115. Hwang GS, Oh KS, Koo HN, Seo HW, You KH, Lee BH (2006) Effects of KR-31378, a novel ATP-sensitive potassium channel activator, on hypertrophy of H9c2 cells and on cardiac dysfunction in rats with congestive heart failure. Eur J Pharmacol 540:131-138. doi: 10.1016/j.ejphar.2006.04.031 (Pubitemid 43890929)
116. Ichihara S, Obata K, Yamada Y, Nagata K, Noda A, Ichihara G, Yamada A, Kato T, Izawa H, Murohara T, Yokota M (2006) Attenuation of cardiac dysfunction by a PPAR-alpha agonist is associated with down-regulation of redox-regulated transcription factors. J Mol Cell Cardiol 41:318-329. doi: 10.1016/j.yjmcc.2006. 05.013 (Pubitemid 44080222)
117. Ikegami T, Suzuki Y, Shimizu T, Isono K, Koseki H, Shirasawa T (2002) Model mice for tissue-specific deletion of the manganese superoxide dismutase (MnSOD) gene. Biochem Biophys Res Commun 296:729-736
118. Ingalls AM, Dickie MM, Snell GD (1950) Obese, a new mutation in the house mouse. J Hered 41:317-318
119. Inoko M, Kihara Y, Morii I, Fujiwara H, Sasayama S (1994) Transition from compensatory hypertrophy to dilated, failing left ventricles in Dahl salt-sensitive rats. Am J Physiol 267:H2471-H2482
120. Intengan HD, Park JB, Schiffrin EL (1999) Blood pressure and small arteries in DOCA-salt-treated genetically AVP-deficient rats: role of endothelin. Hypertension 34:907-913 (Pubitemid 29501322)
121. Ishibashi S, Goldstein JL, Brown MS, Herz J, Burns DK (1994) Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. J Clin Invest 93:1885-1893. doi: 10.1172/JCI117179 (Pubitemid 24143065)
122. Ito H, Torii M, Suzuki T (1995) Decreased superoxide dismutase activity and increased superoxide anion production in cardiac hypertrophy of spontaneously hypertensive rats. Clin Exp Hypertens 17:803-816
123. +) ATPase modifies the transition from hypertrophy to early heart failure. Circ Res 89:422-429 (Pubitemid 34132658)
124. Iwase M, Bishop SP, Uechi M, Vatner DE, Shannon RP, Kudej RK, Wight DC, Wagner TE, Ishikawa Y, Homcy CJ, Vatner SF (1996) Adverse effects of chronic endogenous sympathetic drive induced by cardiac GS alpha overexpression. Circ Res 78:517-524
125. Janssen SW, Martens GJ, Sweep CG, Ross HA, Hermus AR (1999) In Zucker diabetic fatty rats plasma leptin levels are correlated with plasma insulin levels rather than with body weight. Horm Metab Res 31:610-615. doi: 10.1055/s-2007-978806
126. Jasmin G, Eu HY (1979) Cardiomyopathy of hamster dystrophy. Ann N Y Acad Sci 317:46-58
127. Jeong D, Cha H, Kim E, Kang M, Yang DK, Kim JM, Yoon PO, Oh JG, Bernecker OY, Sakata S, Le TT, Cui L, Lee YH, Kim do H, Woo SH, Liao R, Hajjar RJ, Park WJ (2006) PICOT inhibits cardiac hypertrophy and enhances ventricular function and cardiomyocyte contractility. Circ Res 99:307-314. doi: 10.1161/01.RES. 0000234780.06115.2c (Pubitemid 44174939)
128. Jones LR, Suzuki YJ, Wang W, Kobayashi YM, Ramesh V, Franzini-Armstrong C, Cleemann L, Morad M (1998) Regulation of Ca2+ signaling in transgenic mouse cardiac myocytes overexpressing calsequestrin. J Clin Invest 101:1385-1393. doi: 10.1172/JCI1362 (Pubitemid 28166836)
129. Joseph J, Joseph L, Shekhawat NS, Devi S, Wang J, Melchert RB, Hauer-Jensen M, Kennedy RH (2003) Hyperhomocysteinemia leads to pathological ventricular hypertrophy in normotensive rats. Am J Physiol Heart Circ Physiol 285:H679-686. doi: 10.1152/ajpheart.00145.2003
130. Joseph J, Washington A, Joseph L, Koehler L, Fink LM, Hauer-Jensen M, Kennedy RH (2002) Hyperhomocysteinemia leads to adverse cardiac remodeling in hypertensive rats. Am J Physiol Heart Circ Physiol 283:H2567-2574. doi: 10.1152/ajpheart.00475.2002
131. Junhong W, Jing Y, Jizheng M, Shushu Z, Xiangjian C, Hengfang W, Di Y, Jinan Z (2008) Proteomic analysis of left ventricular diastolic dysfunction hearts in renovascular hypertensive rats. Int J Cardiol 127:198-207. doi: 10.1016/j.ijcard.2007.07.003 (Pubitemid 351787791)
132. Katholi RE, Naftilan AJ, Oparil S (1980) Importance of renal sympathetic tone in the development of DOCA-salt hypertension in the rat. Hypertension 2:266-273 (Pubitemid 10061129)
133. Kawano K, Hirashima T, Mori S, Saitoh Y, Kurosumi M, Natori T (1992) Spontaneous long-term hyperglycemic rat with diabetic complications - Otsuka Long-Evans Tokushima Fatty (Oletf) strain. Diabetes 41:1422-1428
134. Kawase Y, Ly HQ, Prunier F, Lebeche D, Shi Y, Jin H, Hadri L, Yoneyama R, Hoshino K, Takewa Y, Sakata S, Peluso R, Zsebo K, Gwathmey JK, Tardif JC, Tanguay JF, Hajjar RJ (2008) Reversal of cardiac dysfunction after long-term expression of SERCA2a by gene transfer in a pre-clinical model of heart failure. J Am Coll Cardiol 51:1112-1119. doi: 10.1016/j.jacc.2007.12.014 (Pubitemid 351374774)
135. Kay JM, Smith P, Heath D (1969) Electron microscopy of Crotalaria pulmonary hypertension. Thorax 24:511-526
136. Kazumi T, Odaka H, Hozumi T, Ishida Y, Amano N, Yoshino G (1997) Effects of dietary fructose or glucose on triglyceride production and lipogenic enzyme activities in the liver of Wistar fatty rats, an animal model of NIDDM. Endocr J 44:239-245 (Pubitemid 27229868)
137. Kim S, Yoshiyama M, Izumi Y, Kawano H, Kimoto M, Zhan Y, Iwao H (2001) Effects of combination of ACE inhibitor and angiotensin receptor blocker on cardiac remodeling, cardiac function, and survival in rat heart failure. Circulation 103:148-154 (Pubitemid 32050450)
138. +)-ATPase protein levels. Effects on Ca2+ transport and mechanics in compensated pressure-overload hypertrophy and congestive heart failure. Circ Res 77:759-764
139. Klotz S, Hay I, Zhang G, Maurer M, Wang J, Burkhoff D (2006) Development of heart failure in chronic hypertensive Dahl rats: focus on heart failure with preserved ejection fraction. Hypertension 47:901-911. doi: 10.1161/01.HYP. 0000215579.81408.8e (Pubitemid 44297562)
140. Koch WJ, Rockman HA, Samama P, Hamilton RA, Bond RA, Milano CA, Lefkowitz RJ (1995) Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor. Science 268:1350-1353
141. Konduracka E, Gackowski A, Rostoff P, Galicka-Latala D, Frasik W, Piwowarska W (2007) Diabetes-specific cardiomyopathy in type 1 diabetes mellitus: no evidence for its occurrence in the era of intensive insulin therapy. Eur Heart J 28:2465-2471. doi: 10.1093/eurheartj/ehm361 (Pubitemid 47614285)
142. Krzeminski TF, Nozynski JK, Grzyb J, Porc M (2008) Wide-spread myocardial remodeling after acute myocardial infarction in rat. Features for heart failure progression. Vascul Pharmacol 48:100-108. doi: 10.1016/j.vph.2008.01.002
143. Kubota T, McTiernan CF, Frye CS, Slawson SE, Lemster BH, Koretsky AP, Demetris AJ, Feldman AM (1997) Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha. Circ Res 81:627-635 (Pubitemid 27432751)
144. Kuhlmann MT, Kirchhof P, Klocke R, Hasib L, Stypmann J, Fabritz L, Stelljes M, Tian W, Zwiener M, Mueller M, Kienast J, Breithardt G, Nikol S (2006) G-CSF/SCF reduces inducible arrhythmias in the infarcted heart potentially via increased connexin43 expression and arteriogenesis. J Exp Med 203:87-97. doi: 10.1084/jem.20051151 (Pubitemid 43139648)
145. Kumar A, Crawford K, Close L, Madison M, Lorenz J, Doetschman T, Pawlowski S, Duffy J, Neumann J, Robbins J, Boivin GP, O'Toole BA, Lessard JL (1997) Rescue of cardiac alpha-actin-deficient mice by enteric smooth muscle gamma-actin. Proc Natl Acad Sci USA 94:4406-4411 (Pubitemid 27194254)
146. Kurrelmeyer KM, Michael LH, Baumgarten G, Taffet GE, Peschon JJ, Sivasubramanian N, Entman ML, Mann DL (2000) Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction. Proc Natl Acad Sci U S A 97:5456-5461. doi: 10.1073/pnas.070036297 (Pubitemid 30313740)
147. Kuwajima I, Kardon MB, Pegram BL, Sesoko S, Frohlich ED (1982) Regression of left ventricular hypertrophy in two-kidney, one clip Goldblatt hypertension. Hypertension 4:113-118
148. Langenickel T, Pagel I, Hohnel K, Dietz R, Willenbrock R (2000) Differential regulation of cardiac ANP and BNP mRNA in different stages of experimental heart failure. Am J Physiol Heart Circ Physiol 278:H1500-H1506
149. Lebrecht D, Kokkori A, Ketelsen UP, Setzer B, Walker UA (2005) Tissue-specific mtDNA lesions and radical-associated mitochondrial dysfunction in human hearts exposed to doxorubicin. J Pathol 207:436-444. doi: 10.1002/path.1863 (Pubitemid 43025692)
150. Leenen FH, de Jong W (1975) Plasma renin and sodium balance during development of moderate and severe renal hypertension in rats. Circ Res 36:179-186
151. Lefrak EA, Pitha J, Rosenheim S, Gottlieb JA (1973) A clinicopathologic analysis of adriamycin cardiotoxicity. Cancer 32:302-314
152. Leite-Moreira AF (2006) Current perspectives in diastolic dysfunction and diastolic heart failure. Heart 92:712-718. doi: 10.1136/hrt.2005.062950
153. Li JM, Yao ZF, Zou YZ, Ge JB, Guan AL, Wu J, Mi SL, Liang YY, Ma Z (2011) The therapeutic potential of G-CSF in pressure overload induced ventricular reconstruction and heart failure in mice. Mol Biol Rep doi: 10.1007/s11033-011- 0703-8
154. Li L, Chu Y, Fink GD, Engelhardt JF, Heistad DD, Chen AF (2003) Endothelin-1 stimulates arterial VCAM-1 expression via NADPH oxidase-derived superoxide in mineralocorticoid hypertension. Hypertension 42:997-1003. doi: 10.1161/01.HYP.0000095980.43859.59 (Pubitemid 37413744)
155. Li Y, Takemura G, Kosai K, Takahashi T, Okada H, Miyata S, Yuge K, Nagano S, Esaki M, Khai NC, Goto K, Mikami A, Maruyama R, Minatoguchi S, Fujiwara T, Fujiwara H (2004) Critical roles for the Fas/Fas ligand system in postinfarction ventricular remodeling and heart failure. Circ Res 95:627-636. doi: 10.1161/01.RES.0000141528.54850.bd (Pubitemid 39274378)
156. Li YY, Feldman AM (2001) Matrix metalloproteinases in the progression of heart failure: potential therapeutic implications. Drugs 61:1239-1252 (Pubitemid 32744406)
157. Li Z, Bing OH, Long X, Robinson KG, Lakatta EG (1997) Increased cardiomyocyte apoptosis during the transition to heart failure in the spontaneously hypertensive rat. Am J Physiol 272:H2313-H2319
158. Li Z, Tran TT, Ma JY, O'Young G, Kapoun AM, Chakravarty S, Dugar S, Schreiner G, Protter AA (2004) p38 alpha mitogen-activated protein kinase inhibition improves cardiac function and reduces myocardial damage in isoproterenol-induced acute myocardial injury in rats. J Cardiovasc Pharmacol 44:486-492. (Pubitemid 39305091)
159. Liggett SB, Tepe NM, Lorenz JN, Canning AM, Jantz TD, Mitarai S, Yatani A, Dorn GW 2nd (2000) Early and delayed consequences of beta(2)-adrenergic receptor overexpression in mouse hearts: critical role for expression level. Circulation 101:1707-1714 (Pubitemid 30196632)
160. Lim CC, Zuppinger C, Guo X, Kuster GM, Helmes M, Eppenberger HM, Suter TM, Liao R, Sawyer DB (2004) Anthracyclines induce calpain-dependent titin proteolysis and necrosis in cardiomyocytes. J Biol Chem 279:8290-8299. doi: 10.1074/jbc.M308033200 (Pubitemid 38294721)
161. Ling H, Zhang T, Pereira L, Means CK, Cheng H, Gu Y, Dalton ND, Peterson KL, Chen J, Bers D, Heller Brown J (2009) Requirement for Ca2+/calmodulin- dependent kinase II in the transition from pressure overload-induced cardiac hypertrophy to heart failure in mice. J Clin Invest 119:1230-1240. doi: 10.1172/JCI38022
162. Litwin SE, Katz SE, Weinberg EO, Lorell BH, Aurigemma GP, Douglas PS (1995) Serial echocardiographic-Doppler assessment of left ventricular geometry and function in rats with pressure-overload hypertrophy. Chronic angiotensin-converting enzyme inhibition attenuates the transition to heart failure. Circulation 91:2642-2654
163. Liu P, Penninger J, Aitken K, Sole M, Mak T (1995) The role of transgenic knockout models in defining the pathogenesis of viral heart disease. Eur Heart J 16 Suppl O:25-27 (Pubitemid 26082338)
164. Liu YH, Yang XP, Nass O, Sabbah HN, Peterson E, Carretero OA (1997) Chronic heart failure induced by coronary artery ligation in Lewis inbred rats. Am J Physiol 272:H722-H727
165. Liu Z, Hilbelink DR, Crockett WB, Gerdes AM (1991) Regional changes in hemodynamics and cardiac myocyte size in rats with aortocaval fistulas. 1. Developing and established hypertrophy. Circ Res 69:52-58
166. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, Gillespie C, Go A, Greenlund K, Haase N, Hailpern S, Ho PM, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott MM, Meigs J, Mozaffarian D, Mussolino M, Nichol G, Roger VL, Rosamond W, Sacco R, Sorlie P, Thom T, Wasserthiel-Smoller S, Wong ND, Wylie-Rosett J (2010) Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 121:e46-e215. doi: 10.1161/ CIRCULATIONAHA.109.192667
167. London B, Baker LC, Lee JS, Shusterman V, Choi BR, Kubota T, McTiernan CF, Feldman AM, Salama G (2003) Calcium-dependent arrhythmias in transgenic mice with heart failure. Am J Physiol Heart Circ Physiol 284:H431-441. doi: 10.1152/ajpheart.00431.2002
168. Lou H, Danelisen I, Singal PK (2004) Cytokines are not upregulated in adriamycin-induced cardiomyopathy and heart failure. J Mol Cell Cardiol 36:683-690. doi: 10.1016/j.yjmcc.2004.03.004 (Pubitemid 38591601)
169. Luo J, Fujikura K, Homma S, Konofagou EE (2007) Myocardial elastography at both high temporal and spatial resolution for the detection of infarcts. Ultrasound Med Biol 33:1206-1223. doi: 10.1016/j.ultrasmedbio.2007.01.019 (Pubitemid 47102518)
170. Luo W, Grupp IL, Harrer J, Ponniah S, Grupp G, Duffy JJ, Doetschman T, Kranias EG (1994) Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation. Circ Res 75:401-409
171. Lygate CA, Schneider JE, Hulbert K, ten Hove M, Sebag-Montefiore LM, Cassidy PJ, Clarke K, Neubauer S (2006) Serial high resolution 3D-MRI after aortic banding in mice: band internalization is a source of variability in the hypertrophic response. Basic Res Cardiol 101:8-16. doi: 10.1007/s00395-005-0546- 3 (Pubitemid 43323427)
172. MacLennan DH, Kranias EG (2003) Phospholamban: a crucial regulator of cardiac contractility. Nat Rev Mol Cell Biol 4:566-577. doi: 10.1038/nrm1151 (Pubitemid 36773408)
173. Maier LS, Wahl-Schott C, Horn W, Weichert S, Pagel C, Wagner S, Dybkova N, Muller OJ, Nabauer M, Franz WM, Pieske B (2005) Increased SR Ca2+ cycling contributes to improved contractile performance in SERCA2a-overexpressing transgenic rats. Cardiovasc Res 67:636-646. doi: 10.1016/j.cardiores.2005.05.006 (Pubitemid 41033359)
174. Mann DL (2002) Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ Res 91:988-998 (Pubitemid 35416635)
175. Manning RD Jr, Meng S, Tian N (2003) Renal and vascular oxidative stress and salt-sensitivity of arterial pressure. Acta Physiol Scand 179:243-250 (Pubitemid 37464109)
176. Marian AJ, Roberts R (2001) The molecular genetic basis for hypertrophic cardiomyopathy. J Mol Cell Cardiol 33:655-670. doi: 10.1006/jmcc.2001.1340 (Pubitemid 32538979)
177. Matsumori A, Kawai C (1982) An experimental model for congestive heart failure after encephalomyocarditis virus myocarditis in mice. Circulation 65:1230-1235 (Pubitemid 12105111)
178. Matsumori A, Sasayama S (1995) Immunomodulating agents for the management of heart failure with myocarditis and cardiomyopathy-lessons from animal experiments. Eur Heart J 16 Suppl O:140-143 (Pubitemid 26082366)
179. Matsumura Y, Hashimoto N, Taira S, Kuro T, Kitano R, Ohkita M, Opgenorth TJ, Takaoka M (1999) Different contributions of endothelin-A and endothelin-B receptors in the pathogenesis of deoxycorticosterone acetate-salt-induced hypertension in rats. Hypertension 33:759-765 (Pubitemid 29091661)
180. McCully JD, Jandreski MA, Liew J, Sole MJ, Liew CC (1987) Construction of cosmid genomic libraries for the normal and myopathic Syrian hamsters. Biochem Cell Biol 65:997-1000
181. McMurray J, Pfeffer MA (2002) New therapeutic options in congestive heart failure: Part I. Circulation 105:2099-2106 (Pubitemid 34465274)
182. McMurray J, Pfeffer MA (2002) New therapeutic options in congestive heart failure: Part II. Circulation 105:2223-2228 (Pubitemid 34517169)
183. Mende U, Kagen A, Cohen A, Aramburu J, Schoen FJ, Neer EJ (1998) Transient cardiac expression of constitutively active Galphaq leads to hypertrophy and dilated cardiomyopathy by calcineurin-dependent and independent pathways. Proc Natl Acad Sci USA 95:13893-13898 (Pubitemid 28523069)
184. Mendez GF, Cowie MR (2001) The epidemiological features of heart failure in developing countries: a review of the literature. Int J Cardiol 80:213-219 (Pubitemid 32905414)
185. Menna P, Recalcati S, Cairo G, Minotti G (2007) An introduction to the metabolic determinants of anthracycline cardiotoxicity. Cardiovasc Toxicol 7:80-85. doi: 10.1007/s12012-007-0011-7 (Pubitemid 47339872)
186. Mering JVMO (1889) Diabetes mellitus nach Pankreasextirpation. Centralblatt fuÂ̈ r klinische Medicin, Leipzig10:383
187. Michael LH, Entman ML, Hartley CJ, Youker KA, Zhu J, Hall SR, Hawkins HK, Berens K, Ballantyne CM (1995) Myocardial ischemia and reperfusion: a murine model. Am J Physiol 269:H2147-H2154
188. Michael O'Donnell J, Narayan P, Bailey MQ, Abduljalil AM, Altschuld RA, McCune SA, Robitaille PM (1998) 31P-NMR analysis of congestive heart failure in the SHHF/Mcc-facp rat heart. J Mol Cell Cardiol 30:235-241. doi: 10.1006/jmcc.1997.0587 (Pubitemid 28116303)
189. Mihm MJ, Yu F, Weinstein DM, Reiser PJ, Bauer JA (2002) Intracellular distribution of peroxynitrite during doxorubicin cardiomyopathy: evidence for selective impairment of myofibrillar creatine kinase. Br J Pharmacol 135:581-588. doi: 10.1038/sj.bjp.0704495 (Pubitemid 34177635)
190. Milano CA, Allen LF, Dolber PC, Johnson TD, Rockman HA, Bond RA, Lefkowitz RJ (1995) Marked enhancement in myocardial function resulting from overexpression of a human beta-adrenergic receptor gene. J Thorac Cardiovasc Surg 109:236-241
191. Milano CA, Dolber PC, Rockman HA, Bond RA, Venable ME, Allen LF, Lefkowitz RJ (1994) Myocardial expression of a constitutively active alpha 1B-adrenergic receptor in transgenic mice induces cardiac hypertrophy. Proc Natl Acad Sci USA 91:10109-10113 (Pubitemid 24311958)
192. Milner DJ, Weitzer G, Tran D, Bradley A, Capetanaki Y (1996) Disruption of muscle architecture and myocardial degeneration in mice lacking desmin. J Cell Biol 134:1255-1270 (Pubitemid 26300170)
193. Minamisawa S, Hoshijima M, Chu G, Ward CA, Frank K, Gu Y, Martone ME, Wang Y, Ross J Jr, Kranias EG, Giles WR, Chien KR (1999) Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy. Cell 99:313-322 (Pubitemid 29519910)
194. Mitchell GF, Pfeffer JM, Pfeffer MA (1997) The transition to failure in the spontaneously hypertensive rat. Am J Hypertens 10:120S-126S (Pubitemid 27239845)
195. Moens AL, Champion HC, Claeys MJ, Tavazzi B, Kaminski PM, Wolin MS, Borgonjon DJ, Van Nassauw L, Haile A, Zviman M, Bedja D, Wuyts FL, Elsaesser RS, Cos P, Gabrielson KL, Lazzarino G, Paolocci N, Timmermans JP, Vrints CJ, Kass DA (2008) High-dose folic acid pretreatment blunts cardiac dysfunction during ischemia coupled to maintenance of high-energy phosphates and reduces postreperfusion injury. Circulation 117:1810-1819. doi: 10.1161/CIRCULATIONAHA. 107.725481 (Pubitemid 351507469)
196. Moens AL, Ketner EA, Takimoto E, Schmidt TS, O'Neill CA, Wolin MS, Alp NJ, Channon KM, Kass DA (2011) Bi-modal dose-dependent cardiac response to tetrahydrobiopterin in pressure-overload induced hypertrophy and heart failure. J Mol Cell Cardiol. doi: 10.1016/j.yjmcc.2011.05.017
197. Moens AL, Leyton-Mange JS, Niu X, Yang R, Cingolani O, Arkenbout EK, Champion HC, Bedja D, Gabrielson KL, Chen J, Xia Y, Hale AB, Channon KM, Halushka MK, Barker N, Wuyts FL, Kaminski PM, Wolin MS, Kass DA, Barouch LA (2009) Adverse ventricular remodeling and exacerbated NOS uncoupling from pressure-overload in mice lacking the beta3-adrenoreceptor. J Mol Cell Cardiol 47:576-585. doi: 10.1016/j.yjmcc.2009.06.005
198. Mohammed SF, Storlie JR, Oehler EA, Bowen LA, Korinek J, Lam CS, Simari RD, Burnett JC Jr, Redfield MM (2011) Variable phenotype in murine transverse aortic constriction. Cardiovasc Pathol. doi: 10.1016/j.carpath.2011.05.002
199. Mohapatra B, Jimenez S, Lin JH, Bowles KR, Coveler KJ, Marx JG, Chrisco MA, Murphy RT, Lurie PR, Schwartz RJ, Elliott PM, Vatta M, McKenna W, Towbin JA, Bowles NE (2003) Mutations in the muscle LIM protein and alpha-actinin-2 genes in dilated cardiomyopathy and endocardial fibroelastosis. Mol Genet Metab 80:207-215 (Pubitemid 37272247)
200. Molina EJ, Gupta D, Palma J, Torres D, Gaughan JP, Houser S, Macha M (2009) Novel experimental model of pressure overload hypertrophy in rats. J Surg Res 153:287-294. doi: 10.1016/j.jss.2008.03.043
201. Molkentin JD, Lu JR, Antos CL, Markham B, Richardson J, Robbins J, Grant SR, Olson EN (1998) A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93:215-228 (Pubitemid 28180855)
202. Molkentin JD, Robbins J (2009) With great power comes great responsibility: using mouse genetics to study cardiac hypertrophy and failure. J Mol Cell Cardiol 46:130-136. doi: 10.1016/j.yjmcc.2008.09.002
203. Monnet E, Chachques JC (2005) Animal models of heart failure: what is new? Ann Thorac Surg 79:1445-1453. doi: 10.1016/j.athoracsur.2004.04.002 (Pubitemid 40431897)
204. Moreau P, Schiffrin EL (2003) Role of endothelins in animal models of hypertension: focus on cardiovascular protection. Can J Physiol Pharmacol 81:511-521. doi: 10.1139/y03-015 (Pubitemid 36836387)
205. Movsesian MA, Kukreja RC (2011) Phosphodiesterase inhibition in heart failure. Handb Exp Pharmacol 237-249 doi: 10.1007/978-3-642-17969-3-10
206. Muller FU, Kirchhefer U, Begrow F, Reinke U, Neumann J, Schmitz W (2002) Junctional sarcoplasmic reticulum transmembrane proteins in the heart. Basic Res Cardiol 97(Suppl 1):I52-I55
207. Murakami K, Mizushige K, Noma T, Tsuji T, Kimura S, Kohno M (2002) Perindopril effect on uncoupling protein and energy metabolism in failing rat hearts. Hypertension 40:251-255 (Pubitemid 35006706)
208. Murata T, Yamawaki H, Yoshimoto R, Hori M, Sato K, Ozaki H, Karaki H (2001) Chronic effect of doxorubicin on vascular endothelium assessed by organ culture study. Life Sci 69:2685-2695 (Pubitemid 32972298)
209. Muth JN, Bodi I, Lewis W, Varadi G, Schwartz A (2001) A Ca(2+)-dependent transgenic model of cardiac hypertrophy: a role for protein kinase Calpha. Circulation 103:140-147 (Pubitemid 32050449)
210. Nagano M, Kato M, Nagai M, Yang J (1991) Protective effect of ACE- and kininase-inhibitor on the onset of cardiomyopathy. Basic Res Cardiol 86(Suppl 3):187-195
211. Nagatsu M, Zile MR, Tsutsui H, Schmid PG, DeFreyte G, Cooper Gt, Carabello BA (1994) Native beta-adrenergic support for left ventricular dysfunction in experimental mitral regurgitation normalizes indexes of pump and contractile function. Circulation 89:818-826 (Pubitemid 24056211)
212. Nigro V, Okazaki Y, Belsito A, Piluso G, Matsuda Y, Politano L, Nigro G, Ventura C, Abbondanza C, Molinari AM, Acampora D, Nishimura M, Hayashizaki Y, Puca GA (1997) Identification of the Syrian hamster cardiomyopathy gene. Hum Mol Genet 6:601-607 (Pubitemid 27142112)
213. Nishio R, Sasayama S, Matsumori A (2002) Left ventricular pressure-volume relationship in a murine model of congestive heart failure due to acute viral myocarditis. J Am Coll Cardiol 40:1506-1514 (Pubitemid 35192878)
214. O'Donnell SM, Hansberger MW, Connolly JL, Chappell JD, Watson MJ, Pierce JM, Wetzel JD, Han W, Barton ES, Forrest JC, Valyi-Nagy T, Yull FE, Blackwell TS, Rottman JN, Sherry B, Dermody TS (2005) Organ-specific roles for transcription factor NF-kappaB in reovirus-induced apoptosis and disease. J Clin Invest 115:2341-2350. doi: 10.1172/JCI22428 (Pubitemid 41266196)
215. Ogata T, Miyauchi T, Sakai S, Takanashi M, Irukayama-Tomobe Y, Yamaguchi I (2004) Myocardial fibrosis and diastolic dysfunction in deoxycorticosterone acetate-salt hypertensive rats is ameliorated by the peroxisome proliferator-activated receptor-alpha activator fenofibrate, partly by suppressing inflammatory responses associated with the nuclear factor-kappa-B pathway. J Am Coll Cardiol 43:1481-1488. doi: 10.1016/j.jacc.2003.11.043 (Pubitemid 38496358)
216. Oudit GY, Crackower MA, Eriksson U, Sarao R, Kozieradzki I, Sasaki T, Irie-Sasaki J, Gidrewicz D, Rybin VO, Wada T, Steinberg SF, Backx PH, Penninger JM (2003) Phosphoinositide 3-kinase gamma-deficient mice are protected from isoproterenol-induced heart failure. Circulation 108:2147-2152. doi: 10.1161/01.CIR.0000091403.62293.2B (Pubitemid 37337593)
217. Ozek C, Zhang F, Lineaweaver WC, Chin BT, Eiman T, Newlin L, Buncke HJ (1998) A new heart failure model in rat by an end-to-side femoral vessel anastomosis. Cardiovasc Res 37:236-238 (Pubitemid 28122636)
218. Pacher P, Nagayama T, Mukhopadhyay P, Batkai S, Kass DA (2008) Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats. Nat Protoc 3:1422-1434. doi: 10.1038/nprot.2008.138
219. Padmanabhan M, Prince PS (2006) Preventive effect of S-allylcysteine on lipid peroxides and antioxidants in normal and isoproterenol-induced cardiotoxicity in rats: a histopathological study. Toxicology 224:128-137. doi: 10.1016/j.tox.2006.04.039
220. Padmanabhan M, Rajadurai M, Prince PS (2008) Preventive effect of S-allylcysteine on membrane-bound enzymes and glycoproteins in normal and isoproterenol-induced cardiac toxicity in male Wistar rats. Basic Clin Pharmacol Toxicol 103:507-513. doi: 10.1111/j.1742-7843.2008.00244.x
221. Paradis P, Dali-Youcef N, Paradis FW, Thibault G, Nemer M (2000) Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling. Proc Natl Acad Sci USA 97:931-936 (Pubitemid 30070412)
222. Park SC, Liu-Stratton Y, Medeiros LC, McCune SA, Radin MJ (2004) Effect of male sex and obesity on platelet arachidonic acid in spontaneous hypertensive heart failure rats. Exp Biol Med (Maywood) 229:657-664 (Pubitemid 38878911)
223. Patten RD, Hall-Porter MR (2009) Small animal models of heart failure: development of novel therapies, past and present. Circ Heart Fail 2:138-144. doi: 10.1161/CIRCHEARTFAILURE.108.839761
224. Peng X, Chen B, Lim CC, Sawyer DB (2005) The cardiotoxicology of anthracycline chemotherapeutics: translating molecular mechanism into preventative medicine. Mol Interv 5:163-171. doi: 10.1124/mi.5.3.6 (Pubitemid 41018273)
225. Periasamy M, Reed TD, Liu LH, Ji Y, Loukianov E, Paul RJ, Nieman ML, Riddle T, Duffy JJ, Doetschman T, Lorenz JN, Shull GE (1999) Impaired cardiac performance in heterozygous mice with a null mutation in the sarco(endo)plasmic reticulum Ca2+-ATPase isoform 2 (SERCA2) gene. J Biol Chem 274:2556-2562 (Pubitemid 29061420)
226. Pfeffer JM, Pfeffer MA, Fishbein MC, Frohlich ED (1979) Cardiac function and morphology with aging in the spontaneously hypertensive rat. Am J Physiol 237:H461-H468
227. Pfeffer JM, Pfeffer MA, Mirsky I, Braunwald E (1982) Regression of left ventricular hypertrophy and prevention of left ventricular dysfunction by captopril in the spontaneously hypertensive rat. Proc Natl Acad Sci USA 79:3310-3314 (Pubitemid 12008396)
228. Pfeffer MA, Pfeffer JM, Fishbein MC, Fletcher PJ, Spadaro J, Kloner RA, Braunwald E (1979) Myocardial infarct size and ventricular function in rats. Circ Res 44:503-512 (Pubitemid 9170880)
229. Pleger ST, Remppis A, Heidt B, Volkers M, Chuprun JK, Kuhn M, Zhou RH, Gao E, Szabo G, Weichenhan D, Muller OJ, Eckhart AD, Katus HA, Koch WJ, Most P (2005) S100A1 gene therapy preserves in vivo cardiac function after myocardial infarction. Mol Ther 12:1120-1129. doi: 10.1016/j.ymthe.2005.08.002 (Pubitemid 41723046)
230. Plestina R, Stoner HB (1972) Pulmonary oedema in rats given monocrotaline pyrrole. J Pathol 106:235-249. doi: 10.1002/path.1711060405
231. Porter CB, Walsh RA, Badke FR, O'Rourke RA (1983) Differential effects of diltiazem and nitroprusside on left ventricular function in experimental chronic volume overload. Circulation 68:685-692 (Pubitemid 13050607)
232. Rakieten N, Rakieten ML, Nadkarni MV (1963) Studies on the diabetogenic action of streptozotocin (NSC-37917). Cancer Chemother Rep 29:91-98
233. Redfern CH, Degtyarev MY, Kwa AT, Salomonis N, Cotte N, Nanevicz T, Fidelman N, Desai K, Vranizan K, Lee EK, Coward P, Shah N, Warrington JA, Fishman GI, Bernstein D, Baker AJ, Conklin BR (2000) Conditional expression of a Gi-coupled receptor causes ventricular conduction delay and a lethal cardiomyopathy. Proc Natl Acad Sci USA 97:4826-4831 (Pubitemid 30238642)
234. Redfield MM (2000) Epidemiology and pathophysiology of heart failure. Curr Cardiol Rep 2:179-180
235. Reed AL, Tanaka A, Sorescu D, Liu H, Jeong EM, Sturdy M, Walp ER, Dudley SC Jr, Sutliff RL (2011) Diastolic dysfunction is associated with cardiac fibrosis in the senescence-accelerated mouse. Am J Physiol Heart Circ Physiol 301:H824-831. doi: 10.1152/ajpheart.00407.2010
236. Rerup CC (1970) Drugs producing diabetes through damage of the insulin secreting cells. Pharmacol Rev 22:485-518
237. Rizzi E, Castro MM, Prado CM, Silva CA, Fazan R Jr, Rossi MA, Tanus-Santos JE, Gerlach RF (2010) Matrix metalloproteinase inhibition improves cardiac dysfunction and remodeling in 2-kidney, 1-clip hypertension. J Card Fail 16:599-608. doi: 10.1016/j.cardfail.2010.02.005
238. Rockman HA, Chien KR, Choi DJ, Iaccarino G, Hunter JJ, Ross J Jr, Lefkowitz RJ, Koch WJ (1998) Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice. Proc Natl Acad Sci USA 95:7000-7005 (Pubitemid 28278096)
239. Rockman HA, Ross RS, Harris AN, Knowlton KU, Steinhelper ME, Field LJ, Ross J Jr, Chien KR (1991) Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy. Proc Natl Acad Sci USA 88:8277-8281 (Pubitemid 21915339)
240. Rockman HA, Wachhorst SP, Mao L, Ross J Jr (1994) ANG II receptor blockade prevents ventricular hypertrophy and ANF gene expression with pressure overload in mice. Am J Physiol 266:H2468-H2475
241. Rodriguez-Iturbe B, Quiroz Y, Kim CH, Vaziri ND (2005) Hypertension induced by aortic coarctation above the renal arteries is associated with immune cell infiltration of the kidneys. Am J Hypertens 18:1449-1456. doi: 10.1016/j.amjhyper.2005.05.034 (Pubitemid 41566674)
242. Rohrer DK, Chruscinski A, Schauble EH, Bernstein D, Kobilka BK (1999) Cardiovascular and metabolic alterations in mice lacking both beta1- and beta2-adrenergic receptors. J Biol Chem 274:16701-16708 (Pubitemid 29275115)
243. Ruiz-Hurtado G, Fernandez-Velasco M, Mourelle M, Delgado C (2007) LA419, a novel nitric oxide donor, prevents pathological cardiac remodeling in pressure-overloaded rats via endothelial nitric oxide synthase pathway regulation. Hypertension 50:1049-1056. doi: 10.1161/HYPERTENSIONAHA.107.093666 (Pubitemid 350172926)
244. Ruiz P, Witt H (2006) Microarray analysis to evaluate different animal models for human heart failure. J Mol Cell Cardiol 40:13-15. doi: 10.1016/j.yjmcc.2005.09.010 (Pubitemid 43012112)
245. Ryu JH, Kim IK, Cho SW, Cho MC, Hwang KK, Piao H, Piao S, Lim SH, Hong YS, Choi CY, Yoo KJ, Kim BS (2005) Implantation of bone marrow mononuclear cells using injectable fibrin matrix enhances neovascularization in infarcted myocardium. Biomaterials 26:319-326. doi: 10.1016/j.biomaterials.2004.02.058 (Pubitemid 38950716)
246. Sah VP, Minamisawa S, Tam SP, Wu TH, Dorn GW 2nd, Ross J Jr, Chien KR, Brown JH (1999) Cardiac-specific overexpression of RhoA results in sinus and atrioventricular nodal dysfunction and contractile failure. J Clin Invest 103:1627-1634. doi: 10.1172/JCI6842 (Pubitemid 29534356)
247. Sakamoto A (2004) Electrical and ionic abnormalities in the heart of cardiomyopathic hamsters: in quest of a new paradigm for cardiac failure and lethal arrhythmia. Mol Cell Biochem 259:183-187 (Pubitemid 38519230)
248. Sakamoto A, Abe M, Masaki T (1999) Delineation of genomic deletion in cardiomyopathic hamster. FEBS Lett 447:124-128 (Pubitemid 29134962)
249. Sakamoto A, Ono K, Abe M, Jasmin G, Eki T, Murakami Y, Masaki T, Toyo-oka T, Hanaoka F (1997) Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, delta-sarcoglycan, in hamster: an animal model of disrupted dystrophin-associated glycoprotein complex. Proc Natl Acad Sci USA 94:13873-13878 (Pubitemid 28009677)
250. Sanbe A, Gulick J, Hanks MC, Liang Q, Osinska H, Robbins J (2003) Reengineering inducible cardiac-specific transgenesis with an attenuated myosin
251. Sato Y, Ferguson DG, Sako H, Dorn GW 2nd, Kadambi VJ, Yatani A, Hoit BD, Walsh RA, Kranias EG (1998) Cardiac-specific overexpression of mouse cardiac calsequestrin is associated with depressed cardiovascular function and hypertrophy in transgenic mice. J Biol Chem 273:28470-28477 (Pubitemid 28496153)
252. Sato Y, Kiriazis H, Yatani A, Schmidt AG, Hahn H, Ferguson DG, Sako H, Mitarai S, Honda R, Mesnard-Rouiller L, Frank KF, Beyermann B, Wu G, Fujimori K, Dorn GW 2nd, Kranias EG (2001) Rescue of contractile parameters and myocyte hypertrophy in calsequestrin overexpressing myocardium by phospholamban ablation. J Biol Chem 276:9392-9399. doi: 10.1074/jbc.M006889200
253. Satoh S, Ueda Y, Suematsu N, Oyama J, Kadokami T, Sugano M, Yoshikawa Y, Makino N (2003) Beneficial effects of angiotensin-converting enzyme inhibition on sarcoplasmic reticulum function in the failing heart of the Dahl rat. Circ J 67:705-711 (Pubitemid 36950789)
254. Sawyer DB, Fukazawa R, Arstall MA, Kelly RA (1999) Daunorubicin-induced apoptosis in rat cardiac myocytes is inhibited by dexrazoxane. Circ Res 84:257-265 (Pubitemid 29095566)
255. Sawyer DB, Peng X, Chen B, Pentassuglia L, Lim CC (2010) Mechanisms of anthracycline cardiac injury: can we identify strategies for cardioprotection? Prog Cardiovasc Dis 53:105-113. doi: 10.1016/j.pcad.2010.06.007
256. Scheuermann-Freestone M, Freestone NS, Langenickel T, Hohnel K, Dietz R, Willenbrock R (2001) A new model of congestive heart failure in the mouse due to chronic volume overload. Eur J Heart Fail 3:535-543 (Pubitemid 34619194)
257. Schiffrin EL (2000) Endothelin: role in experimental hypertension. J Cardiovasc Pharmacol 35:S33-S35
258. Schiffrin EL (2001) Role of endothelin-1 in hypertension and vascular disease. Am J Hypertens 14:83S-89S. doi: S089570610102074X (Pubitemid 32506701)
259. Schlenker EH, Kost CK Jr, Likness MM (2004) Effects of long-term captopril and l-arginine treatment on ventilation and blood pressure in obese male SHHF rats. J Appl Physiol 97:1032-1039. doi: 10.1152/japplphysiol.00255. 2004 (Pubitemid 39121429)
260. Schmidt-Supprian M, Rajewsky K (2007) Vagaries of conditional gene targeting. Nat Immunol 8:665-668. doi: 10.1038/ni0707-665 (Pubitemid 46965339)
261. Schmitt JP, Kamisago M, Asahi M, Li GH, Ahmad F, Mende U, Kranias EG, MacLennan DH, Seidman JG, Seidman CE (2003) Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban. Science 299:1410-1413. doi: 10.1126/science.1081578299/5611/1410 (Pubitemid 36254657)
262. Schoental R, Head MA (1955) Pathological changes in rats as a result of treatment with monocrotaline. Br J Cancer 9:229-237
263. Schunkert H, Dzau VJ, Tang SS, Hirsch AT, Apstein CS, Lorell BH (1990) Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. Effects on coronary resistance, contractility, and relaxation. J Clin Invest 86:1913-1920. doi: 10.1172/JCI114924
264. Schwarz B, Percy E, Gao XM, Dart AM, Richardt G, Du XJ (2003) Altered calcium transient and development of hypertrophy in beta2-adrenoceptor overexpressing mice with and without pressure overload. Eur J Heart Fail 5:131-136. (Pubitemid 36383619)
265. Schwinger RH, Bohm M, Erdmann E (1990) Evidence against spare or uncoupled beta-adrenoceptors in the human heart. Am Heart J 119:899-904 (Pubitemid 20133891)
266. Schwinger RH, Bohm M, Schmidt U, Karczewski P, Bavendiek U, Flesch M, Krause EG, Erdmann E (1995) Unchanged protein levels of SERCA II and phospholamban but reduced Ca2+ uptake and Ca(2+)-ATPase activity of cardiac sarcoplasmic reticulum from dilated cardiomyopathy patients compared with patients with nonfailing hearts. Circulation 92:3220-3228
267. Seidman JG, Seidman C (2001) The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell 104:557-567 (Pubitemid 32201950)
268. Selye H (1942) Production of nephrosclerosis by overdosage with desoxycorticosterone acetate. Can Med Assoc J 47:515-519
269. Shai SY, Harpf AE, Babbitt CJ, Jordan MC, Fishbein MC, Chen J, Omura M, Leil TA, Becker KD, Jiang M, Smith DJ, Cherry SR, Loftus JC, Ross RS (2002) Cardiac myocyte-specific excision of the beta1 integrin gene results in myocardial fibrosis and cardiac failure. Circ Res 90:458-464 (Pubitemid 34633916)
270. Shen FM, Xie HH, Ling G, Xu LP, Su DF (2005) Synergistic effects of atenolol and amlodipine for lowering and stabilizing blood pressure in 2K1C renovascular hypertensive rats. Acta Pharmacol Sin 26:1303-1308. doi: 10.1111/j.1745-7254.2005.00185.x (Pubitemid 41607001)
271. Shimizu T, Nojiri H, Kawakami S, Uchiyama S, Shirasawa T (2010) Model mice for tissue-specific deletion of the manganese superoxide dismutase gene. Geriatr Gerontol Int 10(Suppl 1):S70-79. doi: 10.1111/j.1447-0594.2010.00604.x
272. Shusterman V, Usiene I, Harrigal C, Lee JS, Kubota T, Feldman AM, London B (2002) Strain-specific patterns of autonomic nervous system activity and heart failure susceptibility in mice. Am J Physiol Heart Circ Physiol 282:H2076-H2083. doi: 10.1152/ajpheart.00917.2001
273. Sicard P, Oudot A, Guilland JC, Moreau D, Vergely C, Rochette L (2006) Dissociation between vascular oxidative stress and cardiovascular function in Wistar Kyoto and spontaneously hypertensive rats. Vascul Pharmacol 45:112-121. doi: 10.1016/j.vph.2006.04.001 (Pubitemid 44389837)
274. Silberman GA, Fan TH, Liu H, Jiao Z, Xiao HD, Lovelock JD, Boulden BM, Widder J, Fredd S, Bernstein KE, Wolska BM, Dikalov S, Harrison DG, Dudley SC Jr (2010) Uncoupled cardiac nitric oxide synthase mediates diastolic dysfunction. Circulation 121:519-528. doi: 10.1161/CIRCULATIONAHA.109.883777
275. Silver DP, Livingston DM (2001) Self-excising retroviral vectors encoding the Cre recombinase overcome Cre-mediated cellular toxicity. Mol Cell 8:233-243 (Pubitemid 32772921)
276. Simunek T, Sterba M, Popelova O, Adamcova M, Hrdina R, Gersl V (2009) Anthracycline-induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron. Pharmacol Rep 61:154-171
277. Sohal DS, Nghiem M, Crackower MA, Witt SA, Kimball TR, Tymitz KM, Penninger JM, Molkentin JD (2001) Temporally regulated and tissue-specific gene manipulations in the adult and embryonic heart using a tamoxifen-inducible Cre protein. Circ Res 89:20-25 (Pubitemid 34135487)
278. Stansfield WE, Rojas M, Corn D, Willis M, Patterson C, Smyth SS, Selzman CH (2007) Characterization of a model to independently study regression of ventricular hypertrophy. J Surg Res 142:387-393. doi: 10.1016/j.jss.2007.01.037 (Pubitemid 47418820)
279. Stock JH, Reller MD, Sharma S, Pavcnik D, Shiota T, Sahn DJ (1997) Transballoon intravascular ultrasound imaging during balloon angioplasty in animal models with coarctation and branch pulmonary stenosis. Circulation 95:2354-2357 (Pubitemid 27224728)
280. Sun ZJ, Zhang ZE (2005) Historic perspectives and recent advances in major animal models of hypertension. Acta Pharmacol Sin 26:295-301. doi: 10.1111/j.1745-7254.2005.00054.x (Pubitemid 40388064)
281. Surwit RS, Feinglos MN, Rodin J, Sutherland A, Petro AE, Opara EC, Kuhn CM, Rebuffe-Scrive M (1995) Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice. Metabolism 44:645-651
282. Sussman MA, Welch S, Walker A, Klevitsky R, Hewett TE, Price RL, Schaefer E, Yager K (2000) Altered focal adhesion regulation correlates with cardiomyopathy in mice expressing constitutively active rac1. J Clin Invest 105:875-886. doi: 10.1172/JCI8497 (Pubitemid 30203060)
283. Suzuki M, Carlson KM, Marchuk DA, Rockman HA (2002) Genetic modifier loci affecting survival and cardiac function in murine dilated cardiomyopathy. Circulation 105:1824-1829 (Pubitemid 34408893)
284. Szenczi O, Kemecsei P, Holthuijsen MF, van Riel NA, van der Vusse GJ, Pacher P, Szabo C, Kollai M, Ligeti L, Ivanics T (2005) Poly(ADP-ribose) polymerase regulates myocardial calcium handling in doxorubicin-induced heart failure. Biochem Pharmacol 69:725-732. doi: 10.1016/j.bcp.2004.11.023 (Pubitemid 40248615)
285. Takahashi S, Denvir MA, Harder L, Miller DJ, Cobbe SM, Kawakami M, MacFarlane NG, Okabe E (1998) Effects of in vitro and in vivo exposure to doxorubicin (adriamycin) on caffeine-induced Ca2+ release from sarcoplasmic reticulum and contractile protein function in 'chemically-skinned' rabbit ventricular trabeculae. Jpn J Pharmacol 76:405-413 (Pubitemid 28227083)
286. Takeishi Y, Ping P, Bolli R, Kirkpatrick DL, Hoit BD, Walsh RA (2000) Transgenic overexpression of constitutively active protein kinase C epsilon causes concentric cardiac hypertrophy. Circ Res 86:1218-1223 (Pubitemid 30436661)
287. Takemura G, Fujiwara H (2007) Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management. Prog Cardiovasc Dis 49:330-352. doi: 10.1016/j.pcad.2006.10.002 (Pubitemid 46295436)
288. Takemura G, Miyata S, Kawase Y, Okada H, Maruyama R, Fujiwara H (2006) Autophagic degeneration and death of cardiomyocytes in heart failure. Autophagy 2:212-214 (Pubitemid 44030886)
289. Takenaka H, Kihara Y, Iwanaga Y, Onozawa Y, Toyokuni S, Kita T (2006) Angiotensin II, oxidative stress, and extracellular matrix degradation during transition to LV failure in rats with hypertension. J Mol Cell Cardiol 41:989-997. doi: 10.1016/j.yjmcc.2006.07.019 (Pubitemid 44791331)
290. Takimoto E, Champion HC, Li M, Belardi D, Ren S, Rodriguez ER, Bedja D, Gabrielson KL, Wang Y, Kass DA (2005) Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy. Nat Med 11:214-222. doi: 10.1038/nm1175 (Pubitemid 40321358)
291. Taniyama Y, Walsh K (2002) Elevated myocardial Akt signaling ameliorates doxorubicin-induced congestive heart failure and promotes heart growth. J Mol Cell Cardiol 34:1241-1247 (Pubitemid 35244397)
292. Teerlink JR, Pfeffer JM, Pfeffer MA (1994) Progressive ventricular remodeling in response to diffuse isoproterenol-induced myocardial necrosis in rats. Circ Res 75:105-113
293. Terrand J, Xu B, Morrissy S, Dinh TN, Williams S, Chen QM (2011) p21(WAF1/Cip1/Sdi1) knockout mice respond to doxorubicin with reduced cardiotoxicity. Toxicol Appl Pharmacol. doi: 10.1016/j.taap.2011.08.024
294. Toischer K, Rokita AG, Unsold B, Zhu W, Kararigas G, Sossalla S, Reuter SP, Becker A, Teucher N, Seidler T, Grebe C, Preuss L, Gupta SN, Schmidt K, Lehnart SE, Kruger M, Linke WA, Backs J, Regitz-Zagrosek V, Schafer K, Field LJ, Maier LS, Hasenfuss G (2010) Differential cardiac remodeling in preload versus afterload. Circulation 122:993-1003. doi: 10.1161/CIRCULATIONAHA.110.943431
295. Tomlinson KC, Gardiner SM, Hebden RA, Bennett T (1992) Functional consequences of streptozotocin-induced diabetes mellitus, with particular reference to the cardiovascular system. Pharmacol Rev 44:103-150
296. Towbin JA, Bowles NE (2002) The failing heart. Nature 415:227-233. doi: 10.1038/415227a (Pubitemid 34059529)
297. Tsuji T, Del Monte F, Yoshikawa Y, Abe T, Shimizu J, Nakajima-Takenaka C, Taniguchi S, Hajjar RJ, Takaki M (2009) Rescue of Ca2+ overload-induced left ventricular dysfunction by targeted ablation of phospholamban. Am J Physiol Heart Circ Physiol 296:H310-317. doi: 10.1152/ajpheart.00975.2008
298. Ungerer M, Parruti G, Bohm M, Puzicha M, DeBlasi A, Erdmann E, Lohse MJ (1994) Expression of beta-arrestins and beta-adrenergic receptor kinases in the failing human heart. Circ Res 74:206-213
299. Usui S, Yao A, Hatano M, Kohmoto O, Takahashi T, Nagai R, Kinugawa K (2006) Upregulated neurohumoral factors are associated with left ventricular remodeling and poor prognosis in rats with monocrotaline-induced pulmonary arterial hypertension. Circ J 70:1208-1215 (Pubitemid 44387006)
300. Van den Berg DT, de Kloet ER, de Jong W (1994) Central effects of mineralocorticoid antagonist RU-28318 on blood pressure of DOCA-salt hypertensive rats. Am J Physiol 267:E927-E933
301. Van den Bergh A, Flameng W, Herijgers P (2006) Type II diabetic mice exhibit contractile dysfunction but maintain cardiac output by favourable loading conditions. Eur J Heart Fail 8:777-783. doi: 10.1016/j.ejheart.2006.03. 001 (Pubitemid 44781425)
302. van den Meiracker AH (2002) Endothelins and venous tone in DOCA-salt hypertension. J Hypertens 20:587-589 (Pubitemid 34913694)
303. Vicart P, Caron A, Guicheney P, Li Z, Prevost MC, Faure A, Chateau D, Chapon F, Tome F, Dupret JM, Paulin D, Fardeau M (1998) A missense mutation in the alphaB-crystallin chaperone gene causes a desmin-related myopathy. Nat Genet 20:92-95. doi: 10.1038/1765 (Pubitemid 28410353)
304. Wakasaki H, Koya D, Schoen FJ, Jirousek MR, Ways DK, Hoit BD, Walsh RA, King GL (1997) Targeted overexpression of protein kinase C beta2 isoform in myocardium causes cardiomyopathy. Proc Natl Acad Sci USA 94:9320-9325 (Pubitemid 27357827)
305. Wakisaka Y, Niwano S, Niwano H, Saito J, Yoshida T, Hirasawa S, Kawada H, Izumi T (2004) Structural and electrical ventricular remodeling in rat acute myocarditis and subsequent heart failure. Cardiovasc Res 63:689-699. doi: 10.1016/j.cardiores.2004.04.020 (Pubitemid 39078683)
306. Wang QD, Bohlooly YM, Sjoquist PO (2004) Murine models for the study of congestive heart failure: Implications for understanding molecular mechanisms and for drug discovery. J Pharmacol Toxicol Methods 50:163-174. doi: 10.1016/j.vascn.2004.05.005 (Pubitemid 39440714)
307. Wang X, Ren B, Liu S, Sentex E, Tappia PS, Dhalla NS (2003) Characterization of cardiac hypertrophy and heart failure due to volume overload in the rat. J Appl Physiol 94:752-763. doi: 10.1152/japplphysiol.00248.200294/ 2/752 (Pubitemid 36158255)
308. Wang X, Sentex E, Saini HK, Chapman D, Dhalla NS (2005) Upregulation of beta-adrenergic receptors in heart failure due to volume overload. Am J Physiol Heart Circ Physiol 289:H151-159. doi: 10.1152/ajpheart.00066.2005 (Pubitemid 40934093)
309. Weinberg EO, Schoen FJ, George D, Kagaya Y, Douglas PS, Litwin SE, Schunkert H, Benedict CR, Lorell BH (1994) Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis. Circulation 90:1410-1422 (Pubitemid 24284463)
310. Werchan PM, Summer WR, Gerdes AM, McDonough KH (1989) Right ventricular performance after monocrotaline-induced pulmonary hypertension. Am J Physiol 256:H1328-H1336
311. West MB, Rokosh G, Obal D, Velayutham M, Xuan YT, Hill BG, Keith RJ, Schrader J, Guo Y, Conklin DJ, Prabhu SD, Zweier JL, Bolli R, Bhatnagar A (2008) Cardiac myocyte-specific expression of inducible nitric oxide synthase protects against ischemia/reperfusion injury by preventing mitochondrial permeability transition. Circulation 118:1970-1978. doi: 10.1161/CIRCULATIONAHA.108.791533
312. Wettschureck N, Rutten H, Zywietz A, Gehring D, Wilkie TM, Chen J, Chien KR, Offermanns S (2001) Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Galphaq/Galpha11 in cardiomyocytes. Nat Med 7:1236-1240. doi: 10.1038/nm1101-1236 (Pubitemid 33063779)
313. Wilson KM, Sumners C, Hathaway S, Fregly MJ (1986) Mineralocorticoids modulate central angiotensin II receptors in rats. Brain Res 382:87-96 (Pubitemid 16018033)
314. Wood P, Piran S, Liu PP (2011) Diastolic heart failure: progress, treatment challenges, and prevention. Can J Cardiol 27:302-310. doi: 10.1016/j.cjca.2011.02.008
315. Wu JC, Nasseri BA, Bloch KD, Picard MH, Scherrer-Crosbie M (2003) Influence of sex on ventricular remodeling after myocardial infarction in mice. J Am Soc Echocardiogr 16:1158-1162. doi: 10.1067/S0894-7317(03)00648-5 (Pubitemid 37371660)
316. Xiao CY, Chen M, Zsengeller Z, Li H, Kiss L, Kollai M, Szabo C (2005) Poly(ADP-Ribose) polymerase promotes cardiac remodeling, contractile failure, and translocation of apoptosis-inducing factor in a murine experimental model of aortic banding and heart failure. J Pharmacol Exp Ther 312:891-898. doi: 10.1124/jpet.104.077164 (Pubitemid 40293746)
317. Xin HB, Senbonmatsu T, Cheng DS, Wang YX, Copello JA, Ji GJ, Collier ML, Deng KY, Jeyakumar LH, Magnuson MA, Inagami T, Kotlikoff MI, Fleischer S (2002) Oestrogen protects FKBP12.6 null mice from cardiac hypertrophy. Nature 416:334-338. doi: 10.1038/416334a (Pubitemid 34260249)
318. Yamada T, Matsumori A, Wang WZ, Ohashi N, Shiota K, Sasayama S (1999) Apoptosis in congestive heart failure induced by viral myocarditis in mice. Heart Vessels 14:29-37 (Pubitemid 29473827)
319. Yamori Y (1991) Overview: studies on spontaneous hypertension-development from animal models toward man. Clin Exp Hypertens A 13:631-644
320. Yang S, Su L, Wang Z, Liu Z, Kang Y, Lei J (2011) Comparative study on repairing rabbit radius segmental defects with two different proportions of chitosan combined with allogeneic morselized bone. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 25:877-883
321. Yano M, Kobayashi S, Kohno M, Doi M, Tokuhisa T, Okuda S, Suetsugu M, Hisaoka T, Obayashi M, Ohkusa T, Matsuzaki M (2003) FKBP12.6-mediated stabilization of calcium-release channel (ryanodine receptor) as a novel therapeutic strategy against heart failure. Circulation 107:477-484 (Pubitemid 36158052)
322. Yoo B, Lemaire A, Mangmool S, Wolf MJ, Curcio A, Mao L, Rockman HA (2009) Beta1-adrenergic receptors stimulate cardiac contractility and CaMKII activation in vivo and enhance cardiac dysfunction following myocardial infarction. Am J Physiol Heart Circ Physiol 297:H1377-1386. doi: 10.1152/ajpheart.00504.2009
323. Yoshida M, Ohkusa T, Nakashima T, Takanari H, Yano M, Takemura G, Honjo H, Kodama I, Mizukami Y, Matsuzaki M (2011) Alterations in adhesion junction precede gap junction remodelling during the development of heart failure in cardiomyopathic hamsters. Cardiovasc Res 92:95-105. doi: 10.1093/cvr/cvr182
324. Zbinden G, Bagdon RE (1963) Isoproterenol-induced heart necrosis, an experimental model for the study of Angina Pectoris and Myocardial Infarct. Rev Can Biol 22:257-263
325. Zbinden G, Moe RA (1969) Pharmacological studies on heart muscle lesions induced by isoproterenol. Ann N Y Acad Sci 156:294-308
326. Zhou YY, Song LS, Lakatta EG, Xiao RP, Cheng H (1999) Constitutive beta2-adrenergic signalling enhances sarcoplasmic reticulum Ca2+ cycling to augment contraction in mouse heart. J Physiol 521(Pt 2):351-361
327. Zile MR, Brutsaert DL (2002) New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function. Circulation 105:1387-1393 (Pubitemid 34260433)
328. Zisa D, Shabbir A, Mastri M, Suzuki G, Lee T (2009) Intramuscular VEGF repairs the failing heart: role of host-derived growth factors and mobilization of progenitor cells. Am J Physiol Regul Integr Comp Physiol 297:R1503-1515. doi: 10.1152/ajpregu.00227.2009